ArticleMolecular neurobiology2025
Acrylamide-Induced Neuroendocrine Disruption in Adult Male Zebrafish (Danio rerio): Mechanistic Insights into Locomotor, Neuronal, and Reproductive Impairments.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Acrylamide (AA), a well-documented neurotoxin and reproductive toxicant in mammals, poses a potential risk to teleost species, yet its impact on the hypothalamic-pituitary axis and neuroendocrine integrity remains insufficiently explored. This study hypothesises that AA exposure disrupts locomotor behaviour, neurotransmitter homeostasis, and neuroendocrine regulation in adult male zebrafish, impairing reproductive fitness. Using 72 h exposure to 0.5 and 0.75 mM AA, we demonstrate significant alterations in acetylcholinesterase activity, dopamine levels, and Nos1 expression, correlating with locomotor and behavioural deficits. A marked decline in c-Fos immunoreactivity further suggests compromised neuronal activation associated with impaired mating behaviours. Notably, AA perturbs brain neuroendocrine gene expression, including kisspeptins (kiss1, kiss1rb, kiss2, kiss1ra), gnrh3, gonadotropins (fshb, lhb), estrogen receptors (esr1, 2a, 2b), and steroidogenic markers (cyp11a1, cyp17, hsd3b, cyp19a1b), corroborating well with reduced fertilisation efficiency. Mechanistically, oxidative stress characterised by elevated ROS and lipid peroxidation (MDA levels), dysregulated antioxidant systems (catalase, GST, Nox4, Nrf2/Keap1), and altered Cox2 expression drives JNK phosphorylation (activation), Bax/Bcl2 imbalance, Caspase activation, Parp1 cleavage, and DNA fragmentation, triggering brain apoptosis. Intriguingly, increased CD206 and Il-10 expression alongside suppressed proinflammatory mediators potentially hint at altered microglial polarisation and immune modulation in AA-treated brains. While current findings highlight AA-induced neurotoxicity and neuroendocrine disruption in zebrafish, in silico network toxicology analysis could identify AA-susceptible overlapping molecular targets and brain pathways impacting human neuronal and reproductive health. This study offers critical insights into the mechanistic basis of AA toxicity and its relevance in environmental health risk assessment.
Indexed as
Identifiers
41296176What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.